Advertisement
News
Advertisement

Haemonetics ticks up on 2-for-1 split

Mon, 12/03/2012 - 12:33pm
Mass Device

Haemonetics launches a 2-for-1 stock split, sending shares up slightly on Wall Street.

Haemonetics

Haemonetics (NYSE:HAE) put a 2-for-1 stock split into effect Friday, issuing a single share for each share already owned in time for today's trading.

The Braintree, Mass.-based blood management company said the split, in the form of a 100% stock dividend for shareholders of record as of Nov. 9, is aimed at boosting its market capitalization.

That's the number of shares multiplied by their price. Before the split, Haemonetics' market cap was about $1.05 billion; post-split, that number jumped to $2.11 billion.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading